Incyte to Present at Upcoming Investor Conferences
August 30 2016 - 8:00AM
Business Wire
Incyte Corporation (Nasdaq:INCY) announced today that it will
present at the following investor conferences during the month of
September:
- Morgan Stanley Global Healthcare
Conference on Wednesday, September 14, 2016 at 11:05 am (EDT) in
New York; and
- LEERINK Partners Rare Disease &
Immuno-Oncology Roundtable on Thursday, September 29, 2016 at 3:45
pm (EDT) in New York
The presentations will be webcast live and can be accessed at
www.incyte.com in the Investors section under “Events and
Presentations”. Investors interested in listening to the live
webcasts should log on before the start time in order to download
any software required.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based
biopharmaceutical company focused on the discovery, development and
commercialization of proprietary therapeutics. For additional
information on Incyte, please visit the Company's web site at
www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160830005003/en/
Incyte CorporationMediaCatalina Loveman, +1
302-498-6171cloveman@incyte.comorInvestorsMichael Booth,
DPhil, +1 302-498-5914mbooth@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Apr 2023 to Apr 2024